Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.215,02
-0,82%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ MannKind Corporation (MNKD) MannKind Corporation (MNKD) Notizie

MannKind Corporation

MNKD
4,23
0,05 (1,20%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/4/202412:00GLOBEMannKind Repays Certain Debt Obligations
26/3/202421:05GLOBEMannKind Announces CFO Transition
11/3/202411:05GLOBEINHALE-3 Study’s Initial Meal Challenge Results Comparing..
05/3/202412:05GLOBEMannKind Announces New Clinical Data From Inhale-3 Study to..
04/3/202419:01GLOBEMannKind Corporation Announces Participation at Upcoming..
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:00GLOBEMannKind Corporation Reports 2023 Fourth Quarter and Full..
20/2/202412:00GLOBEMannKind Corporation to Hold 2023 Fourth Quarter and Full..
15/2/202412:05GLOBEMannKind Announces Enrollment Goal Completion of INHALE-1..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202412:06EDGAR2Form 8-K - Current report
02/1/202412:05GLOBEMannKind and Sagard Healthcare Enter Into Royalty Purchase..
28/12/202312:00GLOBEMannKind Corporation to Present at 42nd Annual J.P. Morgan..
27/12/202322:15EDGAR2Form 8-K - Current report
16/12/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:09EDGAR2Form 144 - Report of proposed sale of securities
15/12/202301:56EDGAR2Form 144 - Report of proposed sale of securities
14/12/202322:08EDGAR2Form 144 - Report of proposed sale of securities
07/11/202322:05EDGAR2Form 8-K - Current report
07/11/202322:00GLOBEMannKind Corporation Reports 2023 Third Quarter Financial..
06/11/202312:15GLOBEMannKind Announces Completion of Enrollment in U.S. Phase 4..
03/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202300:07EDGAR2Form 144 - Report of proposed sale of securities
31/10/202321:00GLOBEMannKind Corporation to Hold 2023 Third Quarter Financial..
30/10/202311:15GLOBEMannKind Expands Patent Portfolio With New Clofazimine..
04/10/202303:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
03/10/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:51EDGAR2Form 144 - Report of proposed sale of securities
06/9/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202312:00GLOBEMannKind Corporation Announces Participation at Upcoming..
01/9/202322:11EDGAR2Form 144 - Report of proposed sale of securities
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202300:45EDGAR2Form 144 - Report of proposed sale of securities
23/8/202322:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202322:06EDGAR2Form 8-K - Current report
07/8/202322:00GLOBEMannKind Corporation Reports 2023 Second Quarter Financial..
02/8/202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202300:30EDGAR2Form 144 - Report of proposed sale of securities
01/8/202312:00GLOBEMannKind Corporation Announces Participation in the 2023..
31/7/202322:00GLOBEMannKind Corporation to Hold 2023 Second Quarter Financial..
05/7/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202312:05GLOBEMannKind Launches Inhale-3 Study to Address the Most..
Apertura: 4,20 Min: 4,15 Max: 4,365
Chiusura: 4,18

La tua Cronologia

NASDAQ
MNKD
MannKind
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network